In type 2 diabetes, the body's ability to release insulin is impaired, which leads to high blood glucose levels. Research led by Lund University shows how the levels of a particular protein are ...
and the production of this hormone is decreased in insulin resistance and diabetes. 56 The antiatherogenic action of adiponectin might operate through activation of AMP-activated protein kinase ...
Young and colleagues first suspected that cells affected in chronic disease might have a protein mobility problem after observing changes in the behavior of the insulin receptor, a signaling protein ...
Beta Bionics Inc. kicked off the new year with plans for an initial public offering of 7.5 million shares “as soon as practicable.” Expected to be priced at $14 to $16 per share, the IPO would gross ...